Triple-negative breast cancer (TNBC) represents approximately 15% of all breast cancers, lacks expression of estrogen (ER) or progesterone (PR) receptor, and human epidermal growth factor receptor-2 (HER2) overexpression [1]. This evidence concerns the gene ERBB2 and breast cancer.